InvestorsHub Logo
Followers 24
Posts 501
Boards Moderated 1
Alias Born 03/09/2014

Re: None

Tuesday, 10/13/2020 7:43:01 PM

Tuesday, October 13, 2020 7:43:01 PM

Post# of 42856
LLY Monoclonal Antibody + Remidesivir Halted on Safety- - Helps $HGEN’s BET trial case- “Lilly’s ACTIV-3 trial is intended to test a monoclonal antibody developed in partnership with Gilead Sciences' remdesivir, an antiviral drug granted emergency use authorization by the U.S. Food and Drug Administration to treat COVID-19 infections”

https://www.actionnewsjax.com/news/trending/eli-lilly-pauses-late-stage-covid-19-antibody-treatment-trial-amid-safety-concerns/V3LLTEPZNBEDDADEBWFZFH7Q5Y/?outputType=amp